Legacy Capital Partners’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$725K Buy
5,291
+873
+20% +$116K 0.24% 85
2021
Q4
$623K Sell
4,418
-2,952
-40% -$392K 0.2% 97
2021
Q3
$938K Sell
7,370
-88
-1% -$11.6K 0.34% 72
2021
Q2
$939K Buy
7,458
+25
+0.3% +$3.06K 0.34% 76
2021
Q1
$868K Buy
7,433
+284
+4% +$32.8K 0.33% 76
2020
Q4
$811K Buy
+7,149
New +$780K 0.32% 74

Other funds holding XLV

Legacy Capital Partners's XLV Position: Q1 2022 in Review

Legacy Capital Partners increased its State Street Health Care Select Sector SPDR ETF (XLV) stake by 20% in Q1 2022, buying an estimated $116K and bringing the position to 5,291 shares worth $725K. The position accounts for 0.24% of the portfolio, ranked #85.

Legacy Capital Partners first reported a position in XLV in Q4 2020 and has held it in 6 quarters since. The position peaked at $939K in Q2 2021. 1,438 funds tracked by Wall St. Rank hold XLV as of Q1 2022.

  • Legacy Capital Partners held 5,291 shares of State Street Health Care Select Sector SPDR ETF worth $725K as of Q1 2022.
  • Legacy Capital Partners bought 873 State Street Health Care Select Sector SPDR ETF shares in Q1 2022, an estimated $116K.
  • State Street Health Care Select Sector SPDR ETF made up 0.24% of Legacy Capital Partners's portfolio in Q1 2022, its #85 holding.
  • Legacy Capital Partners first reported a position in State Street Health Care Select Sector SPDR ETF in Q4 2020 and has held it in 6 quarters since.
  • Legacy Capital Partners's State Street Health Care Select Sector SPDR ETF position peaked at $939K in Q2 2021.
  • 1,438 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q1 2022.

Based on Legacy Capital Partners's 13F filing for Q1 2022, filed 11 Apr 2022.